Alidac Pharmaceuticals receives zero observations from USFDA
Alidac Pharmaceuticals, the wholly-owned subsidiary ofΒ Zydus Cadila has received zero observations,Β from the US health regulator. The US health regulator had conducted anΒ inspection of its manufacturing...